The pre-requisite of a second-generation glioma PET biomarker

Katalin Borbely, Max Wintermark, Janos Martos, Imre Fedorcsak, L. Bognár, M. Kásler

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Since the introduction of FDG into the field of molecular imaging with positron emission tomography (PET) more than three decades ago, FDG has been the tracer of choice for oncology PET imaging. Despite the relative disadvantages of FDG and the relative benefits of its challengers, FDG remains the most commonly used glioma tracer nowadays. The present article surveys the expectations of the field and gives a concise summary of recent developments; including the issues pertaining to the continued search for an optimal second-generation PET biomarker for glioma. Mini-abstract: The present article gives a concise summary of recent developments; including the issues pertaining to the continued search for an optimal PET biomarker for glioma.

Original languageEnglish
Pages (from-to)11-16
Number of pages6
JournalJournal of the Neurological Sciences
Volume298
Issue number1-2
DOIs
Publication statusPublished - Nov 15 2010

Fingerprint

Glioma
Positron-Emission Tomography
Biomarkers
Molecular Imaging

Keywords

  • Biomarker
  • Glioma
  • PET

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

The pre-requisite of a second-generation glioma PET biomarker. / Borbely, Katalin; Wintermark, Max; Martos, Janos; Fedorcsak, Imre; Bognár, L.; Kásler, M.

In: Journal of the Neurological Sciences, Vol. 298, No. 1-2, 15.11.2010, p. 11-16.

Research output: Contribution to journalArticle

Borbely, Katalin ; Wintermark, Max ; Martos, Janos ; Fedorcsak, Imre ; Bognár, L. ; Kásler, M. / The pre-requisite of a second-generation glioma PET biomarker. In: Journal of the Neurological Sciences. 2010 ; Vol. 298, No. 1-2. pp. 11-16.
@article{edfdab5135dc4f38aaf2245c126d5ad9,
title = "The pre-requisite of a second-generation glioma PET biomarker",
abstract = "Since the introduction of FDG into the field of molecular imaging with positron emission tomography (PET) more than three decades ago, FDG has been the tracer of choice for oncology PET imaging. Despite the relative disadvantages of FDG and the relative benefits of its challengers, FDG remains the most commonly used glioma tracer nowadays. The present article surveys the expectations of the field and gives a concise summary of recent developments; including the issues pertaining to the continued search for an optimal second-generation PET biomarker for glioma. Mini-abstract: The present article gives a concise summary of recent developments; including the issues pertaining to the continued search for an optimal PET biomarker for glioma.",
keywords = "Biomarker, Glioma, PET",
author = "Katalin Borbely and Max Wintermark and Janos Martos and Imre Fedorcsak and L. Bogn{\'a}r and M. K{\'a}sler",
year = "2010",
month = "11",
day = "15",
doi = "10.1016/j.jns.2010.07.024",
language = "English",
volume = "298",
pages = "11--16",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - The pre-requisite of a second-generation glioma PET biomarker

AU - Borbely, Katalin

AU - Wintermark, Max

AU - Martos, Janos

AU - Fedorcsak, Imre

AU - Bognár, L.

AU - Kásler, M.

PY - 2010/11/15

Y1 - 2010/11/15

N2 - Since the introduction of FDG into the field of molecular imaging with positron emission tomography (PET) more than three decades ago, FDG has been the tracer of choice for oncology PET imaging. Despite the relative disadvantages of FDG and the relative benefits of its challengers, FDG remains the most commonly used glioma tracer nowadays. The present article surveys the expectations of the field and gives a concise summary of recent developments; including the issues pertaining to the continued search for an optimal second-generation PET biomarker for glioma. Mini-abstract: The present article gives a concise summary of recent developments; including the issues pertaining to the continued search for an optimal PET biomarker for glioma.

AB - Since the introduction of FDG into the field of molecular imaging with positron emission tomography (PET) more than three decades ago, FDG has been the tracer of choice for oncology PET imaging. Despite the relative disadvantages of FDG and the relative benefits of its challengers, FDG remains the most commonly used glioma tracer nowadays. The present article surveys the expectations of the field and gives a concise summary of recent developments; including the issues pertaining to the continued search for an optimal second-generation PET biomarker for glioma. Mini-abstract: The present article gives a concise summary of recent developments; including the issues pertaining to the continued search for an optimal PET biomarker for glioma.

KW - Biomarker

KW - Glioma

KW - PET

UR - http://www.scopus.com/inward/record.url?scp=77958152580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958152580&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2010.07.024

DO - 10.1016/j.jns.2010.07.024

M3 - Article

VL - 298

SP - 11

EP - 16

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

ER -